• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在II型糖尿病大鼠糖尿病肾病早期,血管内皮生长因子水平升高。

Vascular endothelial growth factor is increased during early stage of diabetic nephropathy in type II diabetic rats.

作者信息

Cha Dae Ryong, Kang Young Sun, Han Sang Youb, Jee Yi Hwa, Han Kum Hyun, Han Jee Young, Kim Young Sik, Kim Nan Hee

机构信息

Department of Internal Medicine, College of Medicine, Korea University, Ansan, South Korea.

出版信息

J Endocrinol. 2004 Oct;183(1):183-94. doi: 10.1677/joe.1.05647.

DOI:10.1677/joe.1.05647
PMID:15525586
Abstract

Vascular endothelial growth factor (VEGF) has been implicated in the pathogenesis of diabetic nephropathy. We investigated serial changes of VEGF in the kidney and assessed whether glomerular and urinary VEGF levels are related to the severity of diabetic nephropathy. Furthermore, we examined the relationship between urinary VEGF levels and the urinary albumin excretion (UAE) rate in Otsuka-Long-Evans-Tokushima-Fatty (OLETF) rats. Glomerular VEGF mRNA expression and protein synthesis were evaluated by the reverse transcription-polymerase chain reaction, immunohistochemical staining and in situ hybridization. Urinary levels of VEGF were determined by enzyme-linked immunosorbent assay. UAE was significantly higher in OLETF rats than in control Long-Evans-Tokushima-Fatty (LETO) rats throughout the study period. Urinary VEGF levels were significantly higher from 25 to 37 weeks, and then gradually reduced until 55 weeks, although the levels were still higher than those in control rats. Urinary VEGF levels also showed a significant positive correlation with UAE (r=0.262, P=0.045) and serum creatinine (r=0.398, P=0.044), and were found to be independently correlated with UAE by Spearman's rank correlation. By immunohistochemical staining and in situ hybridization, VEGF was mainly detected in the podocytes in the glomeruli. Interestingly, a significant increase in VEGF mRNA expression was observed in the early period of diabetic nephropathy, and this was associated with increased urinary VEGF excretion. Thus, the overproduction of VEGF in the diabetic kidney may participate in the pathogenesis of early-stage diabetic nephropathy.

摘要

血管内皮生长因子(VEGF)与糖尿病肾病的发病机制有关。我们研究了肾脏中VEGF的系列变化,并评估肾小球和尿液中VEGF水平是否与糖尿病肾病的严重程度相关。此外,我们在大冢-朗-伊万科-德岛-肥胖(OLETF)大鼠中研究了尿液VEGF水平与尿白蛋白排泄(UAE)率之间的关系。通过逆转录-聚合酶链反应、免疫组织化学染色和原位杂交评估肾小球VEGF mRNA表达和蛋白质合成。通过酶联免疫吸附测定法测定尿液中VEGF的水平。在整个研究期间,OLETF大鼠的UAE显著高于对照长-伊万科-德岛-肥胖(LETO)大鼠。尿液VEGF水平在25至37周时显著升高,然后逐渐降低直至55周,尽管其水平仍高于对照大鼠。尿液VEGF水平还与UAE(r=0.262,P=0.045)和血清肌酐(r=0.398,P=0.044)呈显著正相关,并且通过Spearman等级相关性分析发现其与UAE独立相关。通过免疫组织化学染色和原位杂交,VEGF主要在肾小球足细胞中检测到。有趣的是,在糖尿病肾病早期观察到VEGF mRNA表达显著增加,这与尿液VEGF排泄增加有关。因此,糖尿病肾脏中VEGF的过度产生可能参与早期糖尿病肾病的发病机制。

相似文献

1
Vascular endothelial growth factor is increased during early stage of diabetic nephropathy in type II diabetic rats.在II型糖尿病大鼠糖尿病肾病早期,血管内皮生长因子水平升高。
J Endocrinol. 2004 Oct;183(1):183-94. doi: 10.1677/joe.1.05647.
2
Effects of NADPH oxidase inhibitor on diabetic nephropathy in OLETF rats: the role of reducing oxidative stress in its protective property.NADPH氧化酶抑制剂对OLETF大鼠糖尿病肾病的影响:减轻氧化应激在其保护作用中的作用
Diabetes Res Clin Pract. 2009 Feb;83(2):176-82. doi: 10.1016/j.diabres.2008.10.007. Epub 2008 Dec 25.
3
Plasma and urinary vascular endothelial growth factor and diabetic nephropathy in Type 2 diabetes mellitus.2型糖尿病患者血浆及尿液血管内皮生长因子与糖尿病肾病
Diabet Med. 2004 Jun;21(6):545-51. doi: 10.1111/j.1464-5491.2004.01200.x.
4
Sulodexide improves renal function through reduction of vascular endothelial growth factor in type 2 diabetic rats.舒洛地特通过降低 2 型糖尿病大鼠血管内皮生长因子改善肾功能。
Life Sci. 2013 Jun 21;92(23):1118-24. doi: 10.1016/j.lfs.2013.04.008. Epub 2013 Apr 30.
5
[Expression of VEGF in kidney of diabetic rats].[血管内皮生长因子在糖尿病大鼠肾脏中的表达]
Sichuan Da Xue Xue Bao Yi Xue Ban. 2007 Jul;38(4):633-6.
6
Ferulic acid prevents pathological and functional abnormalities of the kidney in Otsuka Long-Evans Tokushima Fatty diabetic rats.阿魏酸可预防大冢长- Evans 德岛肥胖糖尿病大鼠的肾脏病理和功能异常。
Diabetes Res Clin Pract. 2008 Jan;79(1):11-7. doi: 10.1016/j.diabres.2007.08.009. Epub 2007 Sep 25.
7
A neutralizing VEGF antibody prevents glomerular hypertrophy in a model of obese type 2 diabetes, the Zucker diabetic fatty rat.一种中和性血管内皮生长因子(VEGF)抗体可预防肥胖型2型糖尿病模型——Zucker糖尿病脂肪大鼠的肾小球肥大。
Nephrol Dial Transplant. 2006 Feb;21(2):324-9. doi: 10.1093/ndt/gfi217. Epub 2005 Oct 25.
8
Inhibition of vascular endothelial growth factor (VEGF) does not affect early renal changes in a rat model of lean type 2 diabetes.抑制血管内皮生长因子(VEGF)并不影响瘦型2型糖尿病大鼠模型的早期肾脏变化。
Horm Metab Res. 2005 Jan;37(1):21-5. doi: 10.1055/s-2005-861027.
9
Urinary excretions of lipocalin-type prostaglandin D2 synthase predict the development of proteinuria and renal injury in OLETF rats.脂质运载蛋白型前列腺素D2合成酶的尿排泄可预测OLETF大鼠蛋白尿和肾损伤的发展。
Nephrol Dial Transplant. 2006 Apr;21(4):924-34. doi: 10.1093/ndt/gfk009. Epub 2005 Dec 29.
10
Activity of the Chinese prescription Hachimi-jio-gan against renal damage in the Otsuka Long-Evans Tokushima fatty rat: a model of human type 2 diabetes mellitus.中药八味地黄丸对大冢长- Evans 德岛肥胖大鼠肾损伤的作用:一种人类 2 型糖尿病模型
J Pharm Pharmacol. 2006 Apr;58(4):535-45. doi: 10.1211/jpp.58.4.0014.

引用本文的文献

1
Vascular endothelial growth factor signaling in health and disease: from molecular mechanisms to therapeutic perspectives.健康与疾病中的血管内皮生长因子信号传导:从分子机制到治疗前景
Signal Transduct Target Ther. 2025 May 19;10(1):170. doi: 10.1038/s41392-025-02249-0.
2
Longitudinal renal function changes during real-world anti-vascular endothelial growth factor therapy for diabetic macular edema in Japan.日本糖尿病性黄斑水肿患者在现实世界中接受抗血管内皮生长因子治疗期间的肾功能纵向变化
Jpn J Ophthalmol. 2025 Mar;69(2):245-252. doi: 10.1007/s10384-025-01170-x. Epub 2025 Feb 28.
3
Association between renal function and the Treatment of Diabetic Macular Edema in Long-Term Cohort Study.
肾功能与长期队列研究中糖尿病性黄斑水肿治疗的关系。
Sci Rep. 2024 Oct 30;14(1):26098. doi: 10.1038/s41598-024-77530-3.
4
Early Detection of Diabetic Peripheral Neuropathy in Diabetic Patients: A Cross-Sectional Study.糖尿病患者的糖尿病周围神经病变的早期检测:一项横断面研究。
Curr Diabetes Rev. 2024;21(2):e280324228439. doi: 10.2174/0115733998297210240325062747.
5
Hirudin in the Treatment of Chronic Kidney Disease.水蛭素在慢性肾脏病治疗中的应用。
Molecules. 2024 Feb 27;29(5):1029. doi: 10.3390/molecules29051029.
6
Prevalence and predictors of developing vision-threatening diabetic retinopathy within the first three years of type 2 diabetes.2 型糖尿病发病后前 3 年内发生威胁视力的糖尿病视网膜病变的患病率及预测因素。
Front Endocrinol (Lausanne). 2023 Dec 20;14:1305378. doi: 10.3389/fendo.2023.1305378. eCollection 2023.
7
Serum VEGF as a predictive marker of glycemic control and diabetic nephropathy in Chinese older adults with type 2 diabetes mellitus.血清 VEGF 可作为中国老年 2 型糖尿病患者血糖控制和糖尿病肾病的预测指标。
Front Endocrinol (Lausanne). 2023 Nov 22;14:1274025. doi: 10.3389/fendo.2023.1274025. eCollection 2023.
8
Sodium Butyrate as Key Regulator of Mitochondrial Function and Barrier Integrity of Human Glomerular Endothelial Cells.丁酸钠作为人肾小球内皮细胞线粒体功能和屏障完整性的关键调节因子。
Int J Mol Sci. 2023 Aug 23;24(17):13090. doi: 10.3390/ijms241713090.
9
Retinal microvascular changes in diabetic patients with diabetic nephropathy.糖尿病肾病患者的视网膜微血管变化。
BMC Endocr Disord. 2023 May 5;23(1):101. doi: 10.1186/s12902-022-01250-w.
10
Inhibition of Xanthine Oxidase Protects against Diabetic Kidney Disease through the Amelioration of Oxidative Stress via VEGF/VEGFR Axis and NOX-FoxO3a-eNOS Signaling Pathway.黄嘌呤氧化酶抑制通过改善氧化应激通过 VEGF/VEGFR 轴和 NOX-FoxO3a-eNOS 信号通路保护糖尿病肾病。
Int J Mol Sci. 2023 Feb 14;24(4):3807. doi: 10.3390/ijms24043807.